0 XP   0   0   0

Mayne Pharma Group Ltd
Buy, Hold or Sell?

I guess you are interested in Mayne Pharma Group Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Mayne Pharma Group Ltd

Let's start. I'm going to help you getting a better view of Mayne Pharma Group Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Mayne Pharma Group Ltd even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Mayne Pharma Group Ltd is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Mayne Pharma Group Ltd. The closing price on 2022-10-03 was A$0.27 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Mayne Pharma Group Ltd Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

1.1. Profitability of Mayne Pharma Group Ltd.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Mayne Pharma Group Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Mayne Pharma Group Ltd to the Drug Manufacturers-General industry mean.
  • A Net Profit Margin of -6.4% means that $-0.06 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Mayne Pharma Group Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-6.4%+6.4%
TTM-6.4%YOY-30.3%+23.9%
TTM-6.4%5Y-26.1%+19.7%
5Y-26.1%10Y-8.2%-17.9%
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.9%-12.9%
TTM-6.4%14.7%-21.1%
YOY-30.3%13.2%-43.5%
5Y-26.1%13.0%-39.1%
10Y-8.2%14.9%-23.1%
1.1.2. Return on Assets

Shows how efficient Mayne Pharma Group Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Mayne Pharma Group Ltd to the Drug Manufacturers-General industry mean.
  • -0.9% Return on Assets means that Mayne Pharma Group Ltd generated $-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Mayne Pharma Group Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.9%+0.9%
TTM-0.9%YOY-3.8%+3.0%
TTM-0.9%5Y-2.3%+1.4%
5Y-2.3%10Y-0.7%-1.6%
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.8%-1.8%
TTM-0.9%2.3%-3.2%
YOY-3.8%1.8%-5.6%
5Y-2.3%2.0%-4.3%
10Y-0.7%2.1%-2.8%
1.1.3. Return on Equity

Shows how efficient Mayne Pharma Group Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Mayne Pharma Group Ltd to the Drug Manufacturers-General industry mean.
  • 0.0% Return on Equity means the company generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Mayne Pharma Group Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-1.7%+1.7%
TTM-1.7%YOY-7.3%+5.6%
TTM-1.7%5Y-3.9%+2.3%
5Y-3.9%10Y-1.2%-2.7%
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.4%-4.4%
TTM-1.7%4.9%-6.6%
YOY-7.3%4.8%-12.1%
5Y-3.9%4.6%-8.5%
10Y-1.2%4.6%-5.8%

1.2. Operating Efficiency of Mayne Pharma Group Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Mayne Pharma Group Ltd is operating .

  • Measures how much profit Mayne Pharma Group Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Mayne Pharma Group Ltd to the Drug Manufacturers-General industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Mayne Pharma Group Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-1.5%+1.5%
TTM-1.5%YOY-6.5%+5.0%
TTM-1.5%5Y-18.5%+17.0%
5Y-18.5%10Y-1.3%-17.2%
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.2%-17.2%
TTM-1.5%17.2%-18.7%
YOY-6.5%17.2%-23.7%
5Y-18.5%18.2%-36.7%
10Y-1.3%17.6%-18.9%
1.2.2. Operating Ratio

Measures how efficient Mayne Pharma Group Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-General industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Mayne Pharma Group Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.132-0.132
TTM0.132YOY0.517-0.385
TTM0.1325Y0.712-0.581
5Y0.71210Y0.612+0.100
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.091-1.091
TTM0.1321.020-0.888
YOY0.5170.950-0.433
5Y0.7120.960-0.248
10Y0.6120.869-0.257

1.3. Liquidity of Mayne Pharma Group Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Mayne Pharma Group Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-General industry mean).
  • A Current Ratio of 0.84 means the company has $0.84 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Mayne Pharma Group Ltd:

  • The MRQ is 0.838. The company is just not able to pay all its short-term debts. -1
  • The TTM is 1.441. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ0.838TTM1.441-0.603
TTM1.441YOY1.869-0.428
TTM1.4415Y2.023-0.582
5Y2.02310Y1.381+0.642
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8381.432-0.594
TTM1.4411.398+0.043
YOY1.8691.420+0.449
5Y2.0231.392+0.631
10Y1.3811.3810.000
1.3.2. Quick Ratio

Measures if Mayne Pharma Group Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Drug Manufacturers-General industry mean)
  • A Quick Ratio of 0.60 means the company can pay off $0.60 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Mayne Pharma Group Ltd:

  • The MRQ is 0.598. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.865. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.598TTM0.865-0.267
TTM0.865YOY1.091-0.227
TTM0.8655Y1.259-0.394
5Y1.25910Y1.060+0.199
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5980.849-0.251
TTM0.8650.810+0.055
YOY1.0910.788+0.303
5Y1.2590.851+0.408
10Y1.0600.765+0.295

1.4. Solvency of Mayne Pharma Group Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Mayne Pharma Group Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Drug Manufacturers-General industry mean).
  • A Debt to Asset Ratio of 0.57 means that Mayne Pharma Group Ltd assets are financed with 56.7% credit (debt) and the remaining percentage (100% - 56.7%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Mayne Pharma Group Ltd:

  • The MRQ is 0.567. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.506. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.567TTM0.506+0.061
TTM0.506YOY0.466+0.040
TTM0.5065Y0.419+0.087
5Y0.41910Y0.430-0.011
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5670.487+0.080
TTM0.5060.503+0.003
YOY0.4660.540-0.074
5Y0.4190.525-0.106
10Y0.4300.517-0.087
1.4.2. Debt to Equity Ratio

Measures if Mayne Pharma Group Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Drug Manufacturers-General industry mean).
  • A Debt to Equity ratio of 129.4% means that company has $1.29 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Mayne Pharma Group Ltd:

  • The MRQ is 1.294. The company is able to pay all its debts with equity. +1
  • The TTM is 1.033. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.294TTM1.033+0.261
TTM1.033YOY0.878+0.155
TTM1.0335Y0.746+0.286
5Y0.74610Y0.850-0.104
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2940.952+0.342
TTM1.0331.0330.000
YOY0.8781.157-0.279
5Y0.7461.140-0.394
10Y0.8501.089-0.239

2. Market Valuation of Mayne Pharma Group Ltd

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Mayne Pharma Group Ltd.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -1.63 means the investor is paying $-1.63 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Mayne Pharma Group Ltd:

  • The EOD is -1.764. Company is losing money. -2
  • The MRQ is -1.634. Company is losing money. -2
  • The TTM is -3.420. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-1.764MRQ-1.634-0.131
MRQ-1.634TTM-3.420+1.786
TTM-3.420YOY-2.464-0.956
TTM-3.4205Y-4.428+1.008
5Y-4.42810Y4.109-8.536
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
EOD-1.76415.914-17.678
MRQ-1.63417.928-19.562
TTM-3.42019.640-23.060
YOY-2.46421.657-24.121
5Y-4.42821.014-25.442
10Y4.10920.535-16.426
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Mayne Pharma Group Ltd.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Mayne Pharma Group Ltd:

  • The MRQ is -0.151. Very Bad. -2
  • The TTM is 0.035. Very good. +2
Trends
Current periodCompared to+/- 
MRQ-0.151TTM0.035-0.187
TTM0.035YOY0.039-0.003
TTM0.0355Y0.029+0.006
5Y0.02910Y0.035-0.006
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.1510.086-0.237
TTM0.0350.002+0.033
YOY0.039-0.076+0.115
5Y0.029-0.050+0.079
10Y0.0350.003+0.032

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Mayne Pharma Group Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-General industry mean).
  • A PB ratio of 0.79 means the investor is paying $0.79 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Mayne Pharma Group Ltd:

  • The EOD is 0.855. Very good. +2
  • The MRQ is 0.792. Very good. +2
  • The TTM is 0.668. Very good. +2
Trends
Current periodCompared to+/- 
EOD0.855MRQ0.792+0.063
MRQ0.792TTM0.668+0.124
TTM0.668YOY0.661+0.006
TTM0.6685Y0.767-0.099
5Y0.76710Y1.462-0.695
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
EOD0.8552.891-2.036
MRQ0.7923.222-2.430
TTM0.6683.587-2.919
YOY0.6613.578-2.917
5Y0.7673.166-2.399
10Y1.4623.020-1.558

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Mayne Pharma Group Ltd.

3.1. Funds holding Mayne Pharma Group Ltd

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2021-01-31DFA International Small Cap Value Portfolio1.37-23019372--
2020-10-31Vanguard International Stock Index-Total Intl Stock Indx1.3300001-22380066--
2020-12-31Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund0.63-10521396--
2021-01-31DFA Asia Pacific Small Company Series0.57-9518774--
2021-02-28iShares MSCI EAFE Small Cap ETF0.39-6505249--
2020-10-31Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index0.26-4447060--
2021-01-31DFA International Core Equity Portfolio0.23-3936421--
2020-12-31College Retirement Equities Fund-Stock Account0.22-3621766--
2020-11-30Schwab Strategic Tr-Schwab International Small Cap Equity ETF0.14-2330522--
2021-01-31TIAA-CREF Funds-Quant International Small Cap Equity Fund0.14-2299815--
Total 5.2800001088580441  

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Mayne Pharma Group Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--0.3160.410-23%0.541-42%0.655-52%0.578-45%
Book Value Per Share Growth---0.128-0.030-76%-0.067-48%-0.029-77%0.004-3082%
Current Ratio--0.8381.441-42%1.869-55%2.023-59%1.381-39%
Debt To Asset Ratio--0.5670.506+12%0.466+22%0.419+35%0.430+32%
Debt To Equity Ratio--1.2941.033+25%0.878+47%0.746+73%0.850+52%
Dividend Per Share----0%-0%-0%-0%
Eps---0.060-0.038-37%-0.035-43%-0.039-36%-0.016-73%
Eps Growth--10.796-30.347+381%-3.459+132%-63.897+692%-19.587+281%
Gains Per Share---0.128-0.030-76%-0.067-48%-0.029-77%0.004-3082%
Gross Profit Margin---0.250-100%0.950-100%1.069-100%0.823-100%
Net Profit Margin----0.0640%-0.3030%-0.2610%-0.0820%
Operating Margin----0.0150%-0.0650%-0.1850%-0.0130%
Operating Ratio---0.132-100%0.517-100%0.712-100%0.612-100%
Pb Ratio0.855+7%0.7920.668+19%0.661+20%0.767+3%1.462-46%
Pe Ratio-1.764-8%-1.634-3.420+109%-2.464+51%-4.428+171%4.109-140%
Peg Ratio---0.1510.035-529%0.039-493%0.029-620%0.035-537%
Price Per Share0.270+7%0.2500.270-7%0.351-29%0.519-52%0.733-66%
Quick Ratio--0.5980.865-31%1.091-45%1.259-53%1.060-44%
Return On Assets----0.0090%-0.0380%-0.0230%-0.0070%
Return On Equity----0.0170%-0.0730%-0.0390%-0.0120%
 EOD+1 -2MRQTTM+4 -11YOY+4 -115Y+4 -1110Y+6 -9

4.2. Fundamental Score

Let's check the fundamental score of Mayne Pharma Group Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.764
Price to Book Ratio (EOD)Between0-10.855
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.598
Current Ratio (MRQ)Greater than10.838
Debt to Asset Ratio (MRQ)Less than10.567
Debt to Equity Ratio (MRQ)Less than11.294
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.000
Total2/10 (20.0%)

4.3. Technical Score

Let's check the technical score of Mayne Pharma Group Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.591
Ma 20Greater thanMa 500.274
Ma 50Greater thanMa 1000.314
Ma 100Greater thanMa 2000.299
OpenGreater thanClose0.272
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets1,287,926
Total Liabilities730,806
Total Stockholder Equity564,773
 As reported
Total Liabilities 730,806
Total Stockholder Equity+ 564,773
Total Assets = 1,287,926

Assets

Total Assets1,287,926
Total Current Assets511,618
Long-term Assets511,618
Total Current Assets
Cash And Cash Equivalents 96,672
Net Receivables 268,241
Inventory 108,908
Other Current Assets 37,797
Total Current Assets  (as reported)511,618
Total Current Assets  (calculated)511,618
+/-0
Long-term Assets
Property Plant Equipment 225,855
Goodwill 22,127
Intangible Assets 405,387
Long-term Assets Other 4,450
Long-term Assets  (as reported)776,308
Long-term Assets  (calculated)657,819
+/- 118,489

Liabilities & Shareholders' Equity

Total Current Liabilities610,421
Long-term Liabilities120,385
Total Stockholder Equity564,773
Total Current Liabilities
Short-term Debt 407,993
Short Long Term Debt 405,367
Accounts payable 63,571
Other Current Liabilities 138,857
Total Current Liabilities  (as reported)610,421
Total Current Liabilities  (calculated)1,015,788
+/- 405,367
Long-term Liabilities
Capital Lease Obligations 8,299
Other Liabilities 114,712
Long-term Liabilities  (as reported)120,385
Long-term Liabilities  (calculated)123,011
+/- 2,626
Total Stockholder Equity
Common Stock1,238,537
Retained Earnings -822,406
Other Stockholders Equity 148,642
Total Stockholder Equity (as reported)564,773
Total Stockholder Equity (calculated)564,773
+/-0
Other
Capital Stock1,238,537
Cash and Short Term Investments 96,672
Common Stock Shares Outstanding 1,764,841
Liabilities and Stockholders Equity 1,295,579
Net Debt 316,994
Net Invested Capital 970,140
Net Tangible Assets -591,904
Net Working Capital -98,803
Short Long Term Debt Total 413,666



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-30
> Total Assets 
29
3,906
3,906
15,511
15,510
13,419
13,419
11,693
11,693
9,504
9,504
8,036
8,036
60,634
60,634
71,148
71,149
63,759
63,759
53,677
53,677
55,401
55,401
50,203
53,933
189,664
189,664
233,391
233,391
256,624
256,624
265,820
265,820
319,941
319,941
528,946
528,946
601,210
601,210
1,525,782
1,557,381
1,947,941
1,947,941
1,908,037
1,914,920
1,729,990
1,729,990
1,830,508
1,830,507
2,012,493
2,012,493
1,636,333
1,636,333
1,868,944
1,868,944
0
1,825,180
0
1,486,966
0
1,463,184
0
1,467,852
0
1,287,926
1,287,92601,467,85201,463,18401,486,96601,825,18001,868,9441,868,9441,636,3331,636,3332,012,4932,012,4931,830,5071,830,5081,729,9901,729,9901,914,9201,908,0371,947,9411,947,9411,557,3811,525,782601,210601,210528,946528,946319,941319,941265,820265,820256,624256,624233,391233,391189,664189,66453,93350,20355,40155,40153,67753,67763,75963,75971,14971,14860,63460,6348,0368,0369,5049,50411,69311,69313,41913,41915,51015,5113,9063,90629
   > Total Current Assets 
0
0
0
0
15,453
0
0
0
11,648
0
0
0
8,013
0
0
0
32,529
0
0
0
18,838
0
0
0
23,255
0
0
0
61,909
0
0
0
65,895
0
0
0
156,820
0
0
0
1,108,650
426,635
426,635
429,003
429,003
420,892
420,892
480,767
480,767
531,786
531,786
471,946
471,946
440,449
440,449
490,947
490,947
465,888
465,888
416,528
416,528
467,734
467,734
511,618
511,618
511,618511,618467,734467,734416,528416,528465,888465,888490,947490,947440,449440,449471,946471,946531,786531,786480,767480,767420,892420,892429,003429,003426,635426,6351,108,650000156,82000065,89500061,90900023,25500018,83800032,5290008,01300011,64800015,4530000
       Cash And Cash Equivalents 
0
0
0
0
15,303
0
0
0
11,531
0
0
0
7,936
0
0
0
19,709
0
0
0
5,807
0
0
0
11,596
0
0
0
18,938
0
0
0
14,813
0
0
0
59,201
0
0
0
47,481
80,820
80,820
63,027
63,027
55,957
55,957
87,312
87,312
96,173
96,173
89,004
89,004
98,529
98,529
0
137,785
0
0
0
97,980
0
0
0
96,672
96,67200097,980000137,785098,52998,52989,00489,00496,17396,17387,31287,31255,95755,95763,02763,02780,82080,82047,48100059,20100014,81300018,93800011,5960005,80700019,7090007,93600011,53100015,3030000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
65
0
0
0
1,825
0
0
0
1,172
0
0
0
2,229
0
0
0
3,458
2,197
2,197
6,208
6,208
5,579
5,579
8,316
6,747
742
742
563
563
734
734
0
443
0
2,743
0
2,733
0
2,478
0
0
002,47802,73302,743044307347345635637427426,7478,3165,5795,5796,2086,2082,1972,1973,4580002,2290001,1720001,82500065000000000000000000000000
       Net Receivables 
0
4
4
80
80
62
62
47
47
49
49
39
39
6,083
6,083
5,999
5,999
7,768
7,768
6,327
5,697
8,895
8,895
3,821
3,821
20,786
20,786
26,853
24,622
29,931
29,931
31,311
29,805
29,640
29,640
68,209
64,657
102,372
102,372
99,679
123,716
215,028
215,028
233,842
232,716
249,475
235,970
274,921
252,715
305,358
298,302
257,103
256,580
219,822
219,822
233,269
195,908
208,656
208,656
193,338
183,283
214,523
214,523
283,019
268,241
268,241283,019214,523214,523183,283193,338208,656208,656195,908233,269219,822219,822256,580257,103298,302305,358252,715274,921235,970249,475232,716233,842215,028215,028123,71699,679102,372102,37264,65768,20929,64029,64029,80531,31129,93129,93124,62226,85320,78620,7863,8213,8218,8958,8955,6976,3277,7687,7685,9995,9996,0836,08339394949474762628080440
       Other Current Assets 
0
10
10
70
70
69
69
71
70
28
28
37
37
777
777
321
321
592
592
281
911
779
779
594
529
1,047
1,047
1,335
2,931
1,044
1,044
1,846
2,869
1,937
1,937
5,333
8,289
8,967
8,967
887,653
895,052
16,862
16,862
10,869
20,658
17,760
17,760
365
51,837
0
25,622
398
26,014
0
28,023
409
63,257
30,291
30,291
13,849
32,755
26,595
26,595
10,116
37,797
37,79710,11626,59526,59532,75513,84930,29130,29163,25740928,023026,01439825,622051,83736517,76017,76020,65810,86916,86216,862895,052887,6538,9678,9678,2895,3331,9371,9372,8691,8461,0441,0442,9311,3351,0471,0475295947797799112815925923213217777773737282870716969707010100
   > Long-term Assets 
0
0
0
0
57
0
0
0
45
0
0
0
23
0
0
0
38,621
0
0
0
34,839
0
0
0
30,678
0
0
0
171,482
0
0
0
199,925
0
0
0
372,126
0
0
0
448,731
0
0
0
1,485,917
0
0
0
1,349,740
0
0
0
1,164,387
0
0
0
1,334,233
0
0
0
1,046,656
0
0
0
776,308
776,3080001,046,6560001,334,2330001,164,3870001,349,7400001,485,917000448,731000372,126000199,925000171,48200030,67800034,83900038,6210002300045000570000
       Property Plant Equipment 
0
0
0
57
57
57
57
45
45
37
37
23
23
19,347
19,347
21,047
21,047
21,275
21,275
21,457
21,457
22,238
22,238
22,224
22,224
56,200
56,200
55,036
55,036
55,593
55,593
53,409
53,409
57,028
57,028
59,597
59,597
65,373
65,373
84,449
84,449
142,336
142,336
189,272
189,272
212,226
212,226
230,051
230,051
237,979
237,979
236,034
236,034
242,894
242,894
238,244
238,244
215,071
215,071
221,595
221,595
220,883
220,883
225,855
225,855
225,855225,855220,883220,883221,595221,595215,071215,071238,244238,244242,894242,894236,034236,034237,979237,979230,051230,051212,226212,226189,272189,272142,336142,33684,44984,44965,37365,37359,59759,59757,02857,02853,40953,40955,59355,59355,03655,03656,20056,20022,22422,22422,23822,23821,45721,45721,27521,27521,04721,04719,34719,34723233737454557575757000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
13,320
13,320
391
391
0
0
391
391
0
0
391
391
391
391
47,197
47,197
50,483
50,483
47,476
47,476
54,689
54,689
58,436
58,436
61,290
61,290
60,115
60,115
61,897
61,897
58,217
58,217
19,583
19,583
20,616
20,616
21,629
21,629
21,725
21,725
21,752
21,752
0
22,174
0
19,826
0
20,346
0
21,020
0
22,127
22,127021,020020,346019,826022,174021,75221,75221,72521,72521,62921,62920,61620,61619,58319,58358,21758,21761,89761,89760,11560,11561,29061,29058,43658,43654,68954,68947,47647,47650,48350,48347,19747,197391391391391003913910039139113,32013,3200000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
13,320
13,320
14,226
13,835
11,225
11,225
8,183
7,792
6,279
6,279
4,194
3,803
3,228
3,228
97,465
68,273
104,080
104,080
107,677
93,639
140,479
140,479
251,398
244,524
258,470
258,470
260,435
272,368
1,212,873
1,212,873
1,143,830
1,177,224
932,570
999,020
931,685
1,033,910
1,041,287
1,157,176
722,534
775,907
968,385
1,026,173
0
940,117
0
623,660
0
615,808
0
550,731
0
405,387
405,3870550,7310615,8080623,6600940,11701,026,173968,385775,907722,5341,157,1761,041,2871,033,910931,685999,020932,5701,177,2241,143,8301,212,8731,212,873272,368260,435258,470258,470244,524251,398140,479140,47993,639107,677104,080104,08068,27397,4653,2283,2283,8034,1946,2796,2797,7928,18311,22511,22513,83514,22613,32013,3200000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
14,612
14,612
17,573
17,573
14,516
14,516
13,382
13,382
10,638
10,638
4,724
8,454
68,817
68,817
116,446
116,446
132,753
132,753
146,516
146,516
191,479
191,479
312,529
312,529
344,489
344,489
364,282
364,282
1,378,970
1,378,970
1,296,645
1,296,645
1,096,872
78,269
167,389
65,164
179,812
63,923
184,094
130,126
195,464
195,464
174,398
174,398
181,776
181,776
-302,376
-302,376
222,556
222,556
-606,224
-606,224
-606,224-606,224222,556222,556-302,376-302,376181,776181,776174,398174,398195,464195,464130,126184,09463,923179,81265,164167,38978,2691,096,8721,296,6451,296,6451,378,9701,378,970364,282364,282344,489344,489312,529312,529191,479191,479146,516146,516132,753132,753116,446116,44668,81768,8178,4544,72410,63810,63813,38213,38214,51614,51617,57317,57314,61214,6120000000000000
> Total Liabilities 
8
183
183
996
996
323
323
255
255
279
279
332
332
41,280
41,280
45,599
45,600
39,289
39,289
29,503
29,503
27,173
27,173
19,603
23,333
82,503
82,503
112,502
112,502
122,825
122,825
106,546
106,546
139,937
139,937
206,744
206,744
249,057
249,057
1,149,561
1,181,160
577,280
577,280
595,613
602,496
596,850
606,420
595,351
595,350
715,087
722,658
622,258
622,258
773,074
778,330
0
782,867
0
715,854
0
691,605
0
722,098
0
730,806
730,8060722,0980691,6050715,8540782,8670778,330773,074622,258622,258722,658715,087595,350595,351606,420596,850602,496595,613577,280577,2801,181,1601,149,561249,057249,057206,744206,744139,937139,937106,546106,546122,825122,825112,502112,50282,50382,50323,33319,60327,17327,17329,50329,50339,28939,28945,60045,59941,28041,2803323322792792552553233239969961831838
   > Total Current Liabilities 
8
183
183
991
991
319
319
253
253
279
279
318
318
13,953
13,953
23,167
23,167
18,219
18,219
14,939
14,939
12,150
12,150
12,304
12,304
30,591
30,591
42,111
42,111
35,654
35,654
30,379
30,379
54,586
54,586
95,078
95,078
132,013
132,013
1,024,325
1,055,924
209,596
209,596
193,012
199,895
186,130
186,130
179,897
179,897
267,249
267,249
211,329
211,329
199,096
199,096
219,253
219,253
249,684
249,684
222,527
222,527
228,904
228,904
610,421
610,421
610,421610,421228,904228,904222,527222,527249,684249,684219,253219,253199,096199,096211,329211,329267,249267,249179,897179,897186,130186,130199,895193,012209,596209,5961,055,9241,024,325132,013132,01395,07895,07854,58654,58630,37930,37935,65435,65442,11142,11130,59130,59112,30412,30412,15012,15014,93914,93918,21918,21923,16723,16713,95313,9533183182792792532533193199919911831838
       Short-term Debt 
0
0
0
0
3
0
0
0
3
0
0
0
2
0
0
0
7,587
0
0
0
2,339
0
0
0
65
0
0
0
7,471
0
0
0
2,374
0
0
0
2,229
0
0
0
503
313,447
313,447
340,246
13,124
359,094
359,094
374,190
58
0
35,538
437
50,881
1,008
41,446
0
44,836
0
46,407
0
54,043
0
51,778
0
407,993
407,993051,778054,043046,407044,836041,4461,00850,88143735,538058374,190359,094359,09413,124340,246313,447313,4475030002,2290002,3740007,471000650002,3390007,5870002000300030000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
313,447
313,447
340,246
340,246
359,094
359,094
374,190
374,190
0
0
437
50,861
1,008
1,008
0
44,836
0
0
0
51,158
0
0
0
405,367
405,36700051,15800044,83601,0081,00850,86143700374,190374,190359,094359,094340,246340,246313,447313,44700000000000000000000000000000000000000000
       Accounts payable 
8
183
183
166
166
305
305
135
135
229
229
119
119
3,611
3,611
2,227
2,227
4,472
4,472
2,142
2,142
4,855
4,855
2,893
2,893
7,866
7,866
6,832
6,832
14,120
14,120
7,131
7,131
14,655
14,655
51,572
51,572
111,602
111,602
64,051
135,508
72,730
72,730
66,593
66,593
58,336
58,336
63,888
63,888
57,548
57,548
50,443
50,443
40,826
40,826
29,842
29,842
43,778
43,778
42,363
42,363
46,260
46,260
63,571
63,571
63,57163,57146,26046,26042,36342,36343,77843,77829,84229,84240,82640,82650,44350,44357,54857,54863,88863,88858,33658,33666,59366,59372,73072,730135,50864,051111,602111,60251,57251,57214,65514,6557,1317,13114,12014,1206,8326,8327,8667,8662,8932,8934,8554,8552,1422,1424,4724,4722,2272,2273,6113,6111191192292291351353053051661661831838
       Other Current Liabilities 
0
0
0
824
821
14
14
118
115
49
49
199
197
4,743
4,743
13,353
13,353
8,873
8,873
10,458
10,458
7,295
7,295
9,411
9,411
20,044
20,044
27,808
27,808
15,319
15,319
20,874
20,874
31,736
31,736
43,506
43,506
20,411
20,411
959,771
919,913
136,494
136,494
113,295
120,178
127,787
127,787
37,526
115,951
50,313
50,313
41,124
110,005
48,742
48,742
70,599
144,575
68,484
68,484
61,260
126,121
65,949
65,949
44,554
138,857
138,85744,55465,94965,949126,12161,26068,48468,484144,57570,59948,74248,742110,00541,12450,31350,313115,95137,526127,787127,787120,178113,295136,494136,494919,913959,77120,41120,41143,50643,50631,73631,73620,87420,87415,31915,31927,80827,80820,04420,0449,4119,4117,2957,29510,45810,4588,8738,87313,35313,3534,7434,74319719949491151181414821824000
   > Long-term Liabilities 
0
0
0
0
6
0
0
0
2
0
0
0
14
0
0
0
22,433
0
0
0
14,564
0
0
0
11,029
0
0
0
70,391
0
0
0
76,167
0
0
0
111,666
0
0
0
125,236
0
0
0
402,601
0
0
0
415,453
0
0
0
410,929
0
0
0
563,614
0
0
0
469,078
0
0
0
120,385
120,385000469,078000563,614000410,929000415,453000402,601000125,236000111,66600076,16700070,39100011,02900014,56400022,43300014000200060000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
359,087
0
374,132
0
337,775
0
318,501
0
343,388
0
353,211
0
287,409
0
292,776
0
332,695
0
0
00332,6950292,7760287,4090353,2110343,3880318,5010337,7750374,1320359,0870000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
6
6
4
4
2
2
1
1
14
14
21,904
21,904
15,856
15,856
16,141
16,141
10,086
10,086
10,510
10,510
7,299
7,299
9,109
9,109
10,594
10,594
15,242
15,242
8,726
8,726
8,785
8,785
8,557
8,557
7,206
7,206
7,265
7,265
6,421
6,421
18,567
18,567
16,949
16,949
41,322
41,322
110,063
110,063
92,428
92,428
230,590
230,590
210,403
210,403
175,374
175,374
176,302
176,302
157,392
157,392
114,712
114,712
114,712114,712157,392157,392176,302176,302175,374175,374210,403210,403230,590230,59092,42892,428110,063110,06341,32241,32216,94916,94918,56718,5676,4216,4217,2657,2657,2067,2068,5578,5578,7858,7858,7268,72615,24215,24210,59410,5949,1099,1097,2997,29910,51010,51010,08610,08616,14116,14115,85615,85621,90421,904141411224466000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
83,819
83,819
91,611
91,611
86,033
86,033
102,225
102,225
115,889
115,889
53,373
53,373
57,788
57,788
40,700
40,700
19,255
19,255
-491,283
-491,283
15,072
15,072
-729,163
-729,163
-729,163-729,16315,07215,072-491,283-491,28319,25519,25540,70040,70057,78857,78853,37353,373115,889115,889102,225102,22586,03386,03391,61191,61183,81983,81900000000000000000000000000000000000000000
> Total Stockholder Equity
21
3,724
3,724
14,514
14,514
13,096
13,096
11,438
11,438
9,224
9,224
7,704
7,704
19,354
19,354
25,549
25,550
24,470
24,470
24,174
24,174
28,228
28,228
30,600
30,600
107,161
107,161
120,889
120,889
133,799
133,799
159,274
159,274
180,004
180,004
310,870
310,870
341,578
341,578
363,749
363,749
1,358,060
1,358,060
1,303,838
1,303,838
1,123,570
1,123,570
1,226,464
1,226,464
1,289,835
1,289,835
1,007,766
1,007,766
1,090,614
1,090,614
0
1,037,547
0
771,112
0
768,357
0
745,754
0
564,773
564,7730745,7540768,3570771,11201,037,54701,090,6141,090,6141,007,7661,007,7661,289,8351,289,8351,226,4641,226,4641,123,5701,123,5701,303,8381,303,8381,358,0601,358,060363,749363,749341,578341,578310,870310,870180,004180,004159,274159,274133,799133,799120,889120,889107,161107,16130,60030,60028,22828,22824,17424,17424,47024,47025,55025,54919,35419,3547,7047,7049,2249,22411,43811,43813,09613,09614,51414,5143,7243,72421
   Common Stock
30
4,074
4,074
15,908
15,908
15,869
15,869
15,869
15,869
15,869
15,869
15,869
15,869
28,689
28,689
29,649
29,649
30,883
30,883
31,870
31,870
32,016
32,016
32,016
32,016
113,234
113,234
118,302
118,302
119,717
119,717
137,498
137,498
137,726
137,726
255,834
255,834
258,712
258,712
263,161
263,161
1,125,331
1,125,331
1,130,404
1,130,404
1,129,725
1,129,725
1,131,761
1,131,761
1,139,615
1,139,615
1,140,008
1,140,008
1,238,081
1,238,081
1,238,584
1,238,584
1,238,584
1,238,584
1,238,537
1,238,537
1,238,537
1,238,537
1,238,537
1,238,537
1,238,5371,238,5371,238,5371,238,5371,238,5371,238,5371,238,5841,238,5841,238,5841,238,5841,238,0811,238,0811,140,0081,140,0081,139,6151,139,6151,131,7611,131,7611,129,7251,129,7251,130,4041,130,4041,125,3311,125,331263,161263,161258,712258,712255,834255,834137,726137,726137,498137,498119,717119,717118,302118,302113,234113,23432,01632,01632,01632,01631,87031,87030,88330,88329,64929,64928,68928,68915,86915,86915,86915,86915,86915,86915,86915,86915,90815,9084,0744,07430
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
439
0
0
0
875
0
0
0
902
0
0
0
1,714
0
0
0
960
0
0
0
1,087
0
0
0
7,461
0
0
0
5,360
0
0
0
30,861
0
0
0
39,058
0
0
0
23,337
0
0
0
71,178
0
0
0
125,099
0
0
0
149,603
0
0
0
88,883
0
0
0
148,642
148,64200088,883000149,603000125,09900071,17800023,33700039,05800030,8610005,3600007,4610001,0870009600001,7140009020008750004390000
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
98,463
98,463
23,337
23,337
10,542
-2,828
71,178
54,086
124,115
103,473
125,099
99,510
127,417
127,417
149,603
149,603
64,454
64,454
88,883
88,883
116,650
116,650
148,642
148,642
148,642148,642116,650116,65088,88388,88364,45464,454149,603149,603127,417127,41799,510125,099103,473124,11554,08671,178-2,82810,54223,33723,33798,46398,46300000000000000000000000000000000000000000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.